FDA Warns Buyers to Avoid Addall XR Shot and Addall XL
By Himiyer News | April 7, 2026
Table of Contents
What Happened
On April 3, 2026, the FDA warned consumers, retailers, and distributors not to use or sell orange-flavored Addall XR Shot or Addall XL capsules from ZMB Enterprises. FDA testing found Addall XR Shot contained phenibut and undeclared 1,4-DMAA, while Addall XL capsules contained DMHA and undeclared 1,4-DMAA.
The agency said DMAA and DMHA can raise blood pressure and increase cardiovascular risk, while phenibut can cause neurocognitive side effects and addiction. FDA also said the company agreed to recall only the shot after being notified in January, but declined to recall Addall XL capsules.
Why It Matters for Buyers
This is a reminder that energy and focus supplements sold online, in gas stations, or in convenience stores can contain undeclared stimulant-like compounds or other unlawful ingredients. For shoppers, the biggest risk is that the label may not match what is actually in the bottle.
What to Watch Next
Buyers should avoid these products and be cautious with supplements promising fast energy, sharper focus, or drug-like effects. FDA said both products pose serious health risks and should be discarded.
